Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

An elderly Chinese man lost all his hair after taking a new heart medication.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

The document is a detailed medical reference on skin and genetic disorders.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.